Parties d'ouvrages collectifs (2)

  1. 1. Delbaere, A., Montanelli, L., Smits, G., Costagliola, S., & Vassart, G. (2006). Genetic aspects of OHSS. In J. Gerris, F. Olivennes, & A. Delvigne (Eds.), Ovarian Hyperstimulation Syndrome (pp. 121-130). Taylor & Francis.(Taylor and Francis Medical Books).
  2. 2. Vassart, G., Bonomi, M., Claeysen, S., Govaerts, C., Ho, S. C., Pardo, L., Smits, G., Vlaeminck-Guillem, V., & Costagliola, S. (2003). Glycoprotein Hormone Receptors: A Unique Paradigm for Ligand Binding and GPCR Activation. In Handbook of Cell Signaling (pp. 161-166). Elsevier Inc. doi:10.1016/B978-012124546-7/50387-9
  3.   Articles dans des revues avec comité de lecture (129)

  4. 1. Lasolle, H., Schiavo, A. A., Tourneur, A., Gillotay, P., De Faria Da Fonseca, B., Ceolin, L., Monestier, O., Aganahi, B. B., Chomette, L., Malta Letro Kizys P., M., Haenebalcke, L., Pieters, T., Goossens, S., Haigh, J. J., Detours, V., Maia, A. L. S., Costagliola, S., & Romitti, M. (2023). Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids. Oncogene.
  5. 2. Romitti, M., & Costagliola, S. (2023). Progress Toward and Challenges Remaining for Thyroid Tissue Regeneration. Endocrinology, 164(10). doi:10.1210/endocr/bqad136
  6. 3. Costagliola, S., & Singh, S. P. (2023). Emerging technologies in thyroid biology: Pushing the frontiers of thyroid research. Molecular and cellular endocrinology, 566-567, 111912. doi:10.1016/j.mce.2023.111912
  7. 4. Chomette, L., Hupkens, E., Romitti, M., Dewachter, L., Vachiery, J.-L., Bailly, S., Costagliola, S., Smits, G., Tillet, E., & Bondue, A. (2023). Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity. American journal of medical genetics. Part A. doi:10.1002/ajmg.a.63236
  8. 5. Carvalho, D. J., Kip, A. M., Romitti, M., Nazzari, M., Tegel, A., Stich, M., Krause, C., Caiment, F., Costagliola, S., Moroni, L., & Giselbrecht, S. (2023). Thyroid‐on‐a‐Chip: An Organoid Platform for In Vitro Assessment of Endocrine Disruption. Advanced Healthcare Materials, 2201555. doi:10.1002/adhm.202201555
  9. 6. Nazzari, M., Romitti, M., Hauser, D., Carvalho, D. J., Giselbrecht, S., Moroni, L., Costagliola, S., & Caiment, F. (2023). Investigation of the effects of phthalates on in vitro thyroid models with RNA-Seq and ATAC-Seq. Frontiers in endocrinology, 14, 1200211. doi:10.3389/fendo.2023.1200211
  10. 7. Ullrich, S., Leidescher, S., Feodorova, Y., Thanisch, K., Finianos, J., Kaspers, B., Weber, F., Markova, B., Führer, D., Romitti, M., Krebs, S., Blum, H., Leonhardt, H., Costagliola, S., Heuer, H., & Solovei, I. (2023). The highly and perpetually upregulated thyroglobulin gene is a hallmark of functional thyrocytes. Frontiers in Cell and Developmental Biology, 11, 1265407. doi:10.3389/fcell.2023.1265407
  11. 8. Romitti, M., Tourneur, A., De Faria Da Fonseca, B., Doumont, G., Gillotay, P., Liao, X. H., Eski, S. E., Van Simaeys, G., Chomette, L., Lasolle, H., Monestier, O., Figini Kasprzyk, D., Detours, V., Singh, S. P., Goldman, S., Refetoff, S., & Costagliola, S. (2022). Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism. Nature communications, 13(1). doi:10.1038/s41467-022-34776-7
  12. 9. Romitti, M., Eski, S. E., De Faria Da Fonseca, B., Gillotay, P., Singh, S. P., & Costagliola, S. (2021). Single-Cell Trajectory Inference Guided Enhancement of Thyroid Maturation In Vitro Using TGF-Beta Inhibition. Frontiers in endocrinology, 12. doi:10.3389/fendo.2021.657195
  13. 10. Sassi, A., Désir, J., Janssens, V., Marangoni, M., Daneels, D., Gheldof, A., Bonduelle, M., Van Dooren, S., Costagliola, S., & Delbaere, A. (2020). Novel inactivating follicle-stimulating hormone receptor mutations in a patient with premature ovarian insufficiency identified by next-generation sequencing gene panel analysis. F and S Reports, 1(3), 193-201. doi:10.1016/j.xfre.2020.08.008

  14. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>